Compare HWM & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HWM | ABT |
|---|---|---|
| Founded | 1888 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.3B | 152.9B |
| IPO Year | 2005 | 2006 |
| Metric | HWM | ABT |
|---|---|---|
| Price | $263.29 | $116.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 20 |
| Target Price | ★ $243.21 | $130.90 |
| AVG Volume (30 Days) | 2.0M | ★ 5.9M |
| Earning Date | 05-07-2026 | 04-16-2026 |
| Dividend Yield | 0.20% | ★ 2.76% |
| EPS Growth | ★ 32.03 | N/A |
| EPS | ★ 2.77 | 0.61 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $14.58 | $10.75 |
| Revenue Next Year | $12.34 | $8.10 |
| P/E Ratio | ★ $98.08 | $191.20 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $170.81 | $81.97 |
| 52 Week High | $310.00 | $137.49 |
| Indicator | HWM | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 33.77 | 75.76 |
| Support Level | $247.27 | $111.18 |
| Resistance Level | $263.54 | $116.82 |
| Average True Range (ATR) | 8.84 | 2.18 |
| MACD | -2.85 | 0.26 |
| Stochastic Oscillator | 0.00 | 90.79 |
Howmet Aerospace Inc offers engineered solutions for the aerospace and transportation industries. The company's products and solutions include investment castings for jet engines and industrial gas turbines; seamless rolled rings for jet engines; fastening systems for aerospace, industrial and commercial transportation applications; forged jet engine components (e.g., jet engine disks); machined and forged aircraft parts; and forged aluminum commercial vehicle wheels, all of which are sold directly to customers or through distributors. It has four reportable segments: Engine Products, which derives key revenue, Fastening Systems, Engineered Structures, and Forged Wheels. Geographically, the company derives maximum revenue from the USA, followed by France, Japan, Germany, and other markets.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.